Allergan set to make headway in crowded CGRP migraine market, as the battle for formulary coverage begins
Millions of migraine sufferers could soon get their hands on an oral CGRP drug designed to be used as-needed, as Allergan $AGN on Wednesday said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
